A pan-cancer analysis of 2,930 patients across 11 tumor types found that ALK mutation was associated with significantly ...

Study in adults and children with aplastic anemia identifies parallel evolutionary pathways used by hematopoietic stem cells to evade immune attack.

Researchers at the University of Oregon have developed an artificial intelligence tool that can read genetic code the way ...

Jordan Adams and Cian Adams carry the genetic mutation that causes frontotemporal dementia, which took the lives of 12 family ...

Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Guardant360® CDx liquid biopsy test as a ...

The saying "cold hands, warm heart" is usually meant metaphorically—but new research from UC Davis School of Medicine and ...

The agency's decision was based on data from the VERITAC-2 trial, which showed Veppanu improved progression-free survival by nearly three months over fulvestrant.

Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...

Patients with EGFR pathway and Fusion Positive mutations had higher Healthy Eating Index-2020 scores than U.S. reference.

Many women who are hemophilia carriers remain undiagnosed and lack access to care, a multinational study reports.